What is Zoster‑related facial weakness?
Zoster‑related facial weakness, also known as herpes zoster oticus or Ramsay Hunt syndrome type 2, occurs when the varicella‑zoster virus (VZV) — the same virus that causes chickenpox and shingles — reactivates in the facial nerve (cranial nerve VII) and sometimes the vestibulocochlear nerve (cranial nerve VIII). The inflammation can damage the nerve fibers that control the muscles of facial expression, leading to partial or complete weakness on one side of the face. Unlike idiopathic Bell’s palsy, the weakness is usually accompanied by a painful skin rash in the ear canal or on the outer ear, but early in the course the rash may be absent or subtle.
Because the facial nerve also carries taste sensation from the anterior two‑ thirds of the tongue and supplies part of the lacrimal (tear) and salivary glands, patients may notice a cluster of sensory changes along with the motor weakness. Prompt recognition and treatment are essential, as delayed therapy can increase the risk of permanent facial asymmetry, hearing loss, or chronic pain.
Common Causes
Facial weakness can result from many different conditions. When the weakness follows a shingles outbreak or is linked to VZV reactivation, it is considered zoster‑related. Below are the most frequent causes of facial weakness that clinicians consider, with emphasis on those that involve VZV:
- Ramsay Hunt syndrome type 2 (herpes zoster oticus) – Reactivation of VZV in the geniculate ganglion of the facial nerve.
- Bell’s palsy (idiopathic facial nerve palsy) – Often viral‑related but without a rash; important for differential diagnosis.
- Other viral reactivations – E.g., herpes simplex virus (HSV‑1) infection of the facial nerve.
- Lyme disease – Borrelia burgdorferi infection can cause facial nerve palsy, typically bilateral.
- Stroke (central facial palsy) – Involves the opposite side of the face and often spares the forehead.
- Temporal bone fractures or trauma – Direct injury to the facial nerve as it passes through the temporal bone.
- Neoplastic compression – Tumors such as acoustic neuroma, parotid gland cancer, or schwannoma.
- Middle‑ear infections (otitis media) or mastoiditis – Can spread inflammation to the facial nerve.
- Autoimmune disorders – Guillain‑Barré syndrome (Miller Fisher variant) or sarcoidosis (facial nerve involvement).
- Diabetes mellitus – Microvascular ischemia of the facial nerve can mimic zoster‑related weakness.
Associated Symptoms
Facial weakness caused by VZV usually appears with a constellation of other signs that help differentiate it from other facial palsies.
- Painful vesicular rash around the ear, external auditory canal, or on the face (often described as “shingles in the ear”).
- Ear symptoms: otalgia (ear pain), tinnitus, hyperacusis (sensitivity to sound), or a feeling of fullness.
- Hearing loss (usually sensorineural) on the affected side.
- Vertigo or imbalance if the vestibular portion of cranial nerve VIII is involved.
- Altered taste on the anterior two‑thirds of the tongue.
- Dry eye or excessive tearing (reduced lacrimal secretion or hyperlacrimation).
- Difficulty closing the eye on the affected side, leading to corneal abrasion risk.
- Facial droop affecting the forehead, eyelid, cheek, and mouth; may cause drooling.
- Facial numbness or paresthesia in the ear or around the jaw.
When to See a Doctor
Facial weakness can progress rapidly. Seek medical attention promptly if you experience any of the following:
- Sudden onset of facial drooping, especially if it involves the forehead.
- Severe ear pain or a rash with blisters around the ear, face, or mouth.
- Hearing loss, ringing in the ears, or dizziness accompanying the weakness.
- Inability to close the eye on the affected side.
- Difficulty speaking, chewing, or swallowing.
- Signs of infection such as fever, chills, or a spreading rash.
- Any facial weakness that does not improve within 48‑72 hours of symptom onset.
Early evaluation (ideally within 72 hours) improves the chance of full recovery and reduces the likelihood of permanent facial asymmetry.
Diagnosis
Evaluation of zoster‑related facial weakness combines a focused history, physical examination, and targeted investigations.
Clinical assessment
- History: onset timing, nature of ear pain, rash appearance, recent stress or immunosuppression, prior chickenpox, vaccination status.
- Physical exam: inspection of facial movement (raise eyebrows, close eyes, smile, puff cheeks), evaluation of the ear canal for vesicles, otoscopic exam for middle‑ear effusion, audiometric screening, and neurologic exam to rule out central causes.
- House-Brackmann grading is commonly used to stage facial nerve function from I (normal) to VI (total paralysis).
Laboratory and imaging studies
- Polymerase chain reaction (PCR) of vesicular fluid – Detects VZV DNA and confirms the diagnosis.
- Serology – VZV IgM/IgG may be supportive but is less specific.
- Magnetic resonance imaging (MRI) with gadolinium – Shows facial nerve enhancement if inflammation is present; helps exclude tumors or stroke.
- Computed tomography (CT) of the temporal bone – Useful if a fracture or bony abnormality is suspected.
- Audiometry – Baseline hearing test to document any sensorineural loss.
- Blood glucose – Rule out diabetes‑related microvascular neuropathy.
Treatment Options
Therapy combines antiviral medication, corticosteroids, supportive eye care, and, when needed, adjunctive treatments.
Antiviral therapy
- Acyclovir 800 mg five times daily, valacyclovir 1 g three times daily, or famciclovir 500 mg three times daily for 7‑10 days.
- Start as soon as possible (ideally within 72 hours of symptom onset) to limit viral replication and nerve damage. Evidence from the CDC and several randomized trials supports improved facial nerve recovery with early antivirals [1][2].
Corticosteroids
- Prednisone 60 mg daily (or equivalent) for 5 days, then taper over 5‑7 days.
- When combined with antivirals, steroids reduce inflammation and edema of the facial nerve, enhancing the odds of complete recovery [3].
Eye protection
- Artificial tears (preservative‑free) every 1‑2 hours while awake.
- Lubricating ointment at night.
- Tap the eyelid closed gently; consider an eye patch or taping to prevent corneal drying and ulceration.
Physical therapy & facial exercises
- Gentle facial massage and prescribed exercises (e.g., smiling, raising eyebrows) help maintain muscle tone and prevent contractures.
- Neuromuscular retraining is especially useful after the acute phase (after 2‑3 weeks).
Pain management
- Acetaminophen or ibuprofen for mild to moderate pain.
- If neuropathic pain persists, gabapentin or pregabalin may be added (as per CDC guidance on post‑herpetic neuralgia).
Adjunctive therapies (selected cases)
- Intratympanic steroid injection – In refractory cases of vestibular involvement, a single dose of dexamethasone can be considered.
- Botulinum toxin – For synkinesis (involuntary muscle movement) that develops weeks to months after recovery.
Follow‑up care
Patients should be re‑evaluated 1‑2 weeks after initiation of treatment to assess facial function, check for complications (e.g., corneal ulcer), and adjust therapy. Persistent weakness after 3‑4 months may warrant referral to a facial nerve specialist or neuro‑otologist.
Prevention Tips
Because the underlying trigger is VZV reactivation, the most effective preventive strategies target the virus itself and general immune health.
- Shingles vaccination: The recombinant zoster vaccine (Shingrix) is >90 % effective at preventing shingles and post‑herpetic complications in adults ≥50 years (CDC [4]). People with immunocompromise should discuss vaccine timing with their provider.
- Maintain a healthy immune system: Adequate sleep, balanced nutrition, regular exercise, and stress reduction lower the risk of VZV reactivation.
- Control chronic illnesses: Tight glucose control in diabetes and optimal management of HIV or other immunosuppressive conditions reduce viral re‑emergence.
- Avoid trauma to the ear: Protect ears from penetrating injuries or loud noises that could precipitate inflammation.
- Prompt treatment of chickenpox in children (when indicated) can limit the viral load that later resides in nerve ganglia.
Emergency Warning Signs
- Sudden, severe facial weakness accompanied by difficulty breathing, swallowing, or speaking (possible airway compromise).
- Rapidly spreading rash with blisters that become painful, fever > 101 °F (38.3 °C), or signs of systemic infection.
- Sudden loss of vision in one eye or double vision.
- Severe, unrelenting vertigo with vomiting or inability to stand.
- Signs of stroke such as drooping of one side of the face **plus** weakness of the arm or leg on the same side, slurred speech, or confusion.
References:
- Mayo Clinic. Ramsay Hunt syndrome. Updated 2023. https://www.mayoclinic.org.
- CDC. Shingles (Herpes Zoster) Treatment. 2022. https://www.cdc.gov.
- American Academy of Otolaryngology‑Head and Neck Surgery. Clinical practice guideline: Facial Nerve Paralysis, 2021.
- CDC. Shingles (Herpes Zoster) Vaccine. 2024. https://www.cdc.gov.